Amesite Inc. Reports $3.1 Million Net Loss and Significant Revenue Growth in Fiscal Year Ending June 30, 2026

Amesite Inc. reported a net loss of approximately $3.1 million for the fiscal year ending June 30, 2026, a decrease from a net loss of about $3.6 million in the previous year. The company's revenue increased significantly to $364,777, up from $110,459 in the prior fiscal year, primarily driven by business-to-business (B2B) license fees related to its NurseMagic™ application. This strategic pivot towards the healthcare sector has allowed Amesite to expand its customer base while reducing cash burn, reflecting a shift in focus from academic customers to healthcare solutions.

The company has made notable operational advancements, including the launch of a census-based Enterprise tier with electronic medical records (EMR) compatibility and the introduction of the AI-native NurseMagic™ EMR capability. Amesite secured its largest enterprise deployment to date, serving an approximately 2,700-patient census. As of June 30, 2026, Amesite reported a total of 6,549,851 shares outstanding, with a cash balance of $2.4 million, which includes $100,000 in restricted cash.

In terms of expenses, Amesite's general and administrative costs remained relatively stable at $2.5 million, while technology and content development expenses decreased to $613,578 from $691,154. Sales and marketing expenses also saw a reduction, totaling $384,041 compared to $545,030 in the previous year. The company attributed the decrease in expenses to lower advertising costs and savings in employee payroll, which contributed to the overall reduction in net loss.

Amesite's workforce consisted of five full-time employees and one consultant as of June 30, 2026. The company continues to face challenges in establishing a stable revenue source sufficient to cover its operational costs, raising concerns about its ability to continue as a going concern. Management plans to generate cash through financing transactions, including potential offerings of common stock, although these plans are subject to market conditions and cannot be guaranteed.

Looking ahead, Amesite remains focused on expanding its presence in the healthcare sector, leveraging its AI-driven solutions to meet the needs of healthcare professionals and organizations. The company is committed to maintaining fiscal discipline while pursuing growth opportunities, despite the competitive landscape and regulatory challenges inherent in the healthcare technology market.